Skip to Main Content

Paper Details

Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Acta Neuropathol Commun
9
2018
DIPG, DIPGs, EGFR, H3, H3 wild, H3 wild-type DIPG, Medulloblastoma, NRAS, PTEN, Patients, SHH, WNT, adult glioblastoma, diffuse intrinsic pontine glioma, medulloblastoma, patients, pediatric medulloblastoma, primary, primary DIPG, primary medulloblastomas
Author NameAffiliation
Drew Pratt
Chandan Kumar-Sinha
Chandan Kumar-SinhaMichigan Center for Translational Pathology
Pankaj Vats
Pankaj VatsMichigan Center for Translational Pathology
Pankaj Vats
Pankaj VatsMichigan Center for Translational Pathology
Katayoon KasaianOntario Institute for Cancer Research
Katayoon KasaianOntario Institute for Cancer Research
Daniel E Spratt
Tingting Qin
Lili ZhaoUniversity of Michigan School of Public Health ann arbor
Sarah E S LearySeattle Children's Hospital
Eric BouffetHospital for Sick Children
Rajen Mody
Sriram Venneti
Arul M Chinnaiyan
Arul M ChinnaiyanMichigan Center for Translational Pathology
Arul M Chinnaiyan
Arul M ChinnaiyanMichigan Center for Translational Pathology
Maryam FouladiCincinnati Children's Hospital
Nicholas G GottardoMichigan Center for Translational Pathology
Nicholas G GottardoKids Cancer Centre, Telethon Kids Institute
Nicholas G GottardoUniversity of Western Australia
Carl Koschmann
Carl Koschmann
  • 1 - 26

Datasets

Release 1.2